Brinker Capital’s AbbVie ABBV Stock Holding History

Brinker Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$6.78M	Buy	69,026 +20,185	+41%	+$1.78M	0.22%	109
2020 Q1	$3.72M	Sell	48,841 -37,029	-43%	-$3.15M	0.15%	148
2019 Q4	$7.6M	Sell	85,870 -7,826	-8%	-$650K	0.24%	90
2019 Q3	$7.09M	Buy	93,696 +19,204	+26%	+$1.32M	0.24%	94
2019 Q2	$5.42M	Buy	74,492 +44,094	+145%	+$3.47M	0.2%	113
2019 Q1	$2.45M	Buy	30,398 +2,316	+8%	+$189K	0.09%	211
2018 Q4	$2.59M	Sell	28,082 -837	-3%	-$73.6K	0.11%	172
2018 Q3	$2.73M	Sell	28,919 -16,846	-37%	-$1.6M	0.1%	210
2018 Q2	$4.24M	Buy	45,765 +16,603	+57%	+$1.62M	0.16%	133
2018 Q1	$2.76M	Sell	29,162 -513	-2%	-$56.4K	0.11%	195
2017 Q4	$2.87M	Sell	29,675 -1,731	-6%	-$163K	0.11%	188
2017 Q3	$2.79M	Sell	31,406 -23,339	-43%	-$1.78M	0.12%	187
2017 Q2	$3.97M	Buy	54,745 +15,598	+40%	+$1.05M	0.18%	124
2017 Q1	$2.55M	Sell	39,147 -12,609	-24%	-$793K	0.12%	170
2016 Q4	$3.24M	Buy	51,756 +41,098	+386%	+$2.51M	0.18%	125
2016 Q3	$672K	Sell	10,658 -10,523	-50%	-$681K	0.06%	128
2016 Q2	$1.31M	Buy	21,181 +9,388	+80%	+$572K	0.12%	69
2016 Q1	$673K	Buy	+11,793	New	+$657K	0.06%	129
2015 Q3	–	Sell	-154,086	Closed	-$10.4M	–	112
2015 Q2	$10.4M	Buy	+154,086	New	+$10.1M	0.87%	26

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Brinker Capital's ABBV Position: Q2 2020 in Review

Brinker Capital increased its AbbVie (ABBV) stake by 41% in Q2 2020, buying an estimated $1.78M and bringing the position to 69,026 shares worth $6.78M. The position accounts for 0.22% of the portfolio, ranked #109.

Brinker Capital first reported a position in ABBV in Q2 2015 and has held it in 19 quarters since. The position peaked at $10.4M in Q2 2015. 2,412 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

Brinker Capital held 69,026 shares of AbbVie worth $6.78M as of Q2 2020.
Brinker Capital bought 20,185 AbbVie shares in Q2 2020, an estimated $1.78M.
AbbVie made up 0.22% of Brinker Capital's portfolio in Q2 2020, its #109 holding.
Brinker Capital first reported a position in AbbVie in Q2 2015 and has held it in 19 quarters since.
Brinker Capital's AbbVie position peaked at $10.4M in Q2 2015.
2,412 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.